The lower the expression levels of SLC22A6, SLC22A13, SLC25A4, SLC34A1, and SLC44A4 were, the later the clinical stage of ccRCC patients was. This evidence concerns the gene SLC22A6 and nonpapillary renal cell carcinoma.